Clinical Trials

Accrual Status
Limit to SWOG Trials

1049 Results

View
Closed
Phase
Accrual
6%
SWOG Clinical Trial Number
SWOG-200

Plan for a Cooperative Study in the Evaluation of the Effectiveness of Chemotherapeutic Agents in the Treatment of a Broadspectrum of Malignant Diseases in Adults
Activated
06-23-1961
Closed
Phase
SWOG Clinical Trial Number
SWOG-8570

Treatment of Brain Tumors With Intra-Arterial Cis-Platinum and BCNU
Closed
04-15-1987
Closed
Phase
SWOG Clinical Trial Number
SWOG-9001

Study of Alpha Interferon Plus 5-Fluorouracil in Patients with Advanced Renal Cell Carcinoma
Closed
07-15-1990
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8530

Efficacy of Prednisone in Refractory and Relapsing Multiple Myeloma and Measurement of Glucocorticoid Receptors
Closed
01-01-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8276

Evaluation of m-AMSA VP-16-213 and 5-Azacytidine Combination Chemotherapy in Adult Acute Non-Lymphocytic Leukemia
Closed
01-11-1985
Closed
Phase
Accrual
9%
SWOG Clinical Trial Number
SWOG-425/426

6-Mercaptopurine (NSC-755) and 6-Methylmercaptopurine Riboside (NSC-40774) Combination in the Treatment of Adult Acute Leukemia
Closed
11-04-1969
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8510

Intra-Arterial Cis-Platinum and Radiation Therapy in Primary Brain Tumors: A Phase II Randomized Study Comparing Sequential and Combined Treatments.
Closed
11-01-1988
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
SLA01

CHARACTERIZATION OF THE EXPRESSION OF IMMUNE CHECKPOINTS IN GASTRIC CANCER FROM LATIN AMERICAN COUNTRIES
Research Committee(s)
Gastrointestinal Cancer
Open
Phase
Accrual
0%
SWOG Clinical Trial Number
MM1OA-S04

A Phase 2 trial of ASTX727 with standard duration versus shorter duration of venetoclax in genomically heterogenous AML among adults aged 60 or older and less fit for intensive therapy: a myeloMATCH substudy.
Research Committee(s)
myeloMATCH
ClinicalTrials.gov Registry Number
NCT07437950